INFECTIOUS COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECIEVING BIOLOGIC THERAPY

被引：0
|
作者：
Ochoa, C. D. [1 ]
Rajaram, P. [1 ]
Tanukonda, S. [1 ]
Sadikot, R. T. [1 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2016年 / 64卷 / 02期
关键词：
D O I：
10.1136/jim-2015-000035.469
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
467
引用
收藏
页码：679 / 680
页数：2
相关论文
共 50 条
  • [31] Gut Microbial Changes in Inflammatory Bowel Disease Patients in Response to Biologic Therapy
    Yilmaz, Bahtiyar
    Juillerat, Pascal
    Bravo, Francisco D.
    Wiest, Reiner
    Macpherson, Andrew
    SWISS MEDICAL WEEKLY, 2017, 147 : 12S - 12S
  • [32] VACCINATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY, ARE THEY BEING CONSIDERED?
    Chatten, K.
    Cornthwaite, L.
    Nixon, E.
    Goel, A.
    GUT, 2017, 66 : A243 - A244
  • [33] LOWER SUSTAINED PERTUSSIS CONCENTRATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON BIOLOGIC THERAPY
    Caldera, Freddy
    McCrone, Sue
    Garmoe, Christine A.
    Megna, Bryant W.
    Ley, Dana
    Reichelderfer, Mark
    Hayney, Mary S.
    GASTROENTEROLOGY, 2017, 152 (05) : S59 - S59
  • [34] Overuse of Tuberculosis Screening Practices in Patients With Inflammatory Bowel Disease on Biologic Therapy
    Vecchio, Eric
    Mao, Eric
    Fine, Sean
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S369 - S369
  • [35] Biologic therapy and the risk of herpes zoster among patients with inflammatory bowel disease
    Santella, Christina
    Bitton, Alain
    Filliter, Christopher
    Vutcovici, Maria
    Bessissow, Talat
    Lakatos, Peter
    Brassard, Paul
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 607 - 607
  • [36] Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease
    Roig, Clara Amiama
    Ferrer, Cristina Suarez
    Garcia, Jose Luis Rueda
    Cordon, Joaquin Poza
    Sanchez-Azofra, Maria
    Arranz, Eduardo Martin
    Diaz, Irene Gonzalez
    Costa, Carmen Amor
    Martin-Arranz, Maria Dolores
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (02): : 109 - 115
  • [37] Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease
    Abadir, Alexander
    Troia, Angela
    Said, Hyder
    Tarugu, Spurthi
    Billingsley, Benjamin C.
    Sairam, Nathan
    Minchenberg, Scott B.
    Owings, Anna H.
    Parker, Adam M.
    Brousse, Brandon
    Carlyle, Alexander
    Owens, Bobby R.
    Hosseini-Carroll, Pegah
    Galeas-Pena, Michelle
    Frasca, Joseph
    Glover, Sarah C.
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (08) : 2796 - 2803
  • [38] ASSOCIATION OF BIOLOGIC THERAPY OVERLAP WITH THE RISK OF INFECTIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Kruger, Annie J.
    Dormont, Flavio
    Capit, Nicolas
    Schilsky, Samantha
    Roberts, Andrew
    Lin, Yong
    Badalamenti, Salvatore
    Wiekowski, Maria
    Bewtra, Meenakshi
    Colombel, Jean Frederic
    GASTROENTEROLOGY, 2024, 166 (05) : S1132 - S1133
  • [39] Cytokines and Biologic Therapy in Patients with Inflammatory Bowel Diseases
    Caviglia, Gian Paolo
    Ribaldone, Davide Giuseppe
    Nicolosi, Aurora
    Pellicano, Rinaldo
    GASTROENTEROLOGY INSIGHTS, 2021, 12 (04) : 443 - 445
  • [40] Infectious Complications in Liver Transplant Patients Exposed to Vedolizumab for the Treatment of Inflammatory Bowel Disease
    Tse, Chung Sang
    Loftus, Edward V., Jr.
    Raffals, Laura
    Lightner, Amy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S423 - S423
12345